We are live on
!
Find out more
FMT
First Mercantile Trust Portfolio holdings
AUM
$755M
1-Year Est. Return
28.15%
This Fund
S&P 500
This Quarter
Est. Return
+4.54%
1 Year Est. Return
+28.15%
3 Year Est. Return
+51.22%
5 Year Est. Return
+128.6%
10 Year Est. Return
–
AUM
$873M
AUM Growth
-$8.82M
(-1%)
Cap. Flow
-$39.5M
Cap. Flow
% of AUM
-4.53%
Top 10 Holdings %
Top 10 Hldgs %
45.88%
Holding
913
New
65
Increased
172
Reduced
585
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$4.99M |
| 2 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$3.9M |
| 3 |
Snowflake
SNOW
|
+$2.16M |
| 4 |
Align Technology
ALGN
|
+$1.17M |
| 5 |
Zoom
ZM
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$4.7M |
| 2 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.17M |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$4.06M |
| 4 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$2.92M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9% |
| 2 | Consumer Discretionary | 6.27% |
| 3 | Healthcare | 6.19% |
| 4 | Financials | 5.98% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
651
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $110K | 0.01% |
1,603
-189
| -11% | -$15.3K |
|
652
Forrester Research
FORR
$199M
| $109K | 0.01% |
2,573
-331
| -11% | -$14.4K |
|
653
Leidos
LDOS
$14.4B
| $109K | 0.01% |
1,127
-939
| -45% | -$94.9K |
|
654
Northwest Bancshares
NWBI
$2.33B
| $109K | 0.01% |
7,539
-1,392
| -16% | -$19.6K |
|
655
Pinnacle West Capital
PNW
$12.4B
| $109K | 0.01% |
1,340
-140
| -9% | -$10.8K |
|
656
Synchrony
SYF
$24.4B
| $109K | 0.01% |
2,681
-251
| -9% | -$9.68K |
|
|
MODN
657
DELISTED
MODEL N, INC.
MODN
| $109K | 0.01% |
3,091
-94
| -3% | -$3.61K |
|
658
Innospec
IOSP
$2.09B
| $108K | 0.01% |
1,050
| – | – |
|
659
Kura Oncology
KURA
$793M
| $107K | 0.01% |
3,800
+330
| +10% | +$10.4K |
|
660
Monro
MNRO
$414M
| $106K | 0.01% |
1,612
-208
| -11% | -$13K |
|
|
NTST
661
NETSTREIT Corp
NTST
$2.13B
| $106K | 0.01% |
5,735
+2,050
| +56% | +$36.6K |
|
662
Gentherm
THRM
$1.32B
| $106K | 0.01% |
1,429
-461
| -24% | -$32.7K |
|
663
Trupanion
TRUP
$1.13B
| $106K | 0.01% |
1,389
-58
| -4% | -$5.95K |
|
|
CCXI
664
DELISTED
ChemoCentryx, Inc.
CCXI
| $106K | 0.01% |
2,072
-243
| -10% | -$14.6K |
|
|
DRNA
665
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $106K | 0.01% |
4,148
-575
| -12% | -$14.7K |
|
666
Assured Guaranty
AGO
$3.73B
| $105K | 0.01% |
2,482
-419
| -14% | -$16.8K |
|
667
Madrigal Pharmaceuticals
MDGL
$12.6B
| $105K | 0.01% |
897
-79
| -8% | -$9.21K |
|
668
PTC Therapeutics
PTCT
$6.18B
| $105K | 0.01% |
2,220
-260
| -10% | -$15.4K |
|
669
ALX Oncology
ALXO
$262M
| $104K | 0.01% |
1,404
+195
| +16% | +$15.3K |
|
|
JBGS
670
JBG SMITH
JBGS
$846M
| $104K | 0.01% |
3,272
-476
| -13% | -$15.1K |
|
|
TGNA
671
DELISTED
TEGNA Inc
TGNA
| $104K | 0.01% |
5,545
| – | – |
|
|
RVNC
672
DELISTED
Revance Therapeutics, Inc.
RVNC
| $104K | 0.01% |
3,707
-497
| -12% | -$13.7K |
|
673
New Jersey Resources
NJR
$6B
| $103K | 0.01% |
2,593
-331
| -11% | -$12.6K |
|
674
LiveRamp
RAMP
$2.29B
| $103K | 0.01% |
1,984
-358
| -15% | -$24.4K |
|
675
Spire
SR
$4.79B
| $103K | 0.01% |
1,399
-6
| -0.4% | -$401 |
|
Similar funds
LBD
SIM
OAM
KFM
BCA
GIA
CCP
BJ
First Mercantile Trust's Q1 2021 Portfolio in Review
As of Q1 2021, First Mercantile Trust held 913 positions worth $873M, down 1% from $882M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
First Mercantile Trust withdrew a net $39.5M in Q1 2021, closing 73 positions and reducing 585 holdings. Its most notable exit was CoStar Group, an estimated $763K position sold in full.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, First Mercantile Trust opened a new position in 10x Genomics worth $912K.
- First Mercantile Trust's largest Q1 2021 buy was 10x Genomics: 5,036 shares worth $912K.
- First Mercantile Trust added most to Vanguard Intermediate-Term Treasury ETF in Q1 2021, an estimated $4.99M increase.
- First Mercantile Trust's biggest Q1 2021 reduction was Schwab US Large- Cap ETF, cutting an estimated $4.7M.
- First Mercantile Trust fully exited CoStar Group in Q1 2021, selling an estimated $763K.
- First Mercantile Trust's ten largest holdings make up 46% of its $873M portfolio in Q1 2021.
- First Mercantile Trust opened 65 new positions and closed 73 in Q1 2021.
- First Mercantile Trust's portfolio value fell 1% quarter-over-quarter to $873M.
Based on First Mercantile Trust's 13F filing for Q1 2021, filed 14 May 2021.